Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Joshua S. Siegel |
Documentos disponibles escritos por este autor (1)
Refinar búsquedaPsychological support approaches in psychedelic therapy: results from a survey of psychedelic practitioners / David A. Bender en The Journal of Clinical Psychiatry, Año 2025 - Vol. 86 - No.1 (Marzo)
[artículo]
Título : Psychological support approaches in psychedelic therapy: results from a survey of psychedelic practitioners Tipo de documento: texto impreso Autores: David A. Bender, Autor ; Sandeep M. Nayak, Autor ; Joshua S. Siegel, Autor Fecha de publicación: 2025 Artículo en la página: pp. 9-18 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Actitud del personal de salud, Alucinógenos - uso terapéutico, Dietilamida del ácido lisérgico - uso terapéutico, Psilocibina - uso terapéutico. Resumen: To assess the viewpoints of psychedelic practitioners in research settings on approaches to psychological support for psychedelic treatments.
An anonymous survey was distributed via email to contacts listed on ClinicalTrials.gov for clinical trials of psilocybin and LSD, personal contacts of authors, and through snowball sampling. The survey included Likert type, multiple choice, free response, and demographic items.Link: ./index.php?lvl=notice_display&id=31612
in The Journal of Clinical Psychiatry > Año 2025 - Vol. 86 - No.1 (Marzo) . - pp. 9-18[artículo] Psychological support approaches in psychedelic therapy: results from a survey of psychedelic practitioners [texto impreso] / David A. Bender, Autor ; Sandeep M. Nayak, Autor ; Joshua S. Siegel, Autor . - 2025 . - pp. 9-18.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2025 - Vol. 86 - No.1 (Marzo) . - pp. 9-18
Etiquetas: Actitud del personal de salud, Alucinógenos - uso terapéutico, Dietilamida del ácido lisérgico - uso terapéutico, Psilocibina - uso terapéutico. Resumen: To assess the viewpoints of psychedelic practitioners in research settings on approaches to psychological support for psychedelic treatments.
An anonymous survey was distributed via email to contacts listed on ClinicalTrials.gov for clinical trials of psilocybin and LSD, personal contacts of authors, and through snowball sampling. The survey included Likert type, multiple choice, free response, and demographic items.Link: ./index.php?lvl=notice_display&id=31612
